0001127602-17-012348.txt : 20170320 0001127602-17-012348.hdr.sgml : 20170320 20170320150153 ACCESSION NUMBER: 0001127602-17-012348 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170316 FILED AS OF DATE: 20170320 DATE AS OF CHANGE: 20170320 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAAB THOMAS R II CENTRAL INDEX KEY: 0001230708 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 17701228 MAIL ADDRESS: STREET 1: C/O INSPIRE PHARMACEUTICALS, INC. STREET 2: 4222 EMPEROR BLVD., SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2017-03-16 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001230708 STAAB THOMAS R II 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Senior Vice President and CFO Common Stock 2017-03-16 4 M 0 23955 3.78 A 141268 D Common Stock 2017-03-16 4 M 0 12500 1.42 A 153768 D Common Stock 2017-03-16 4 F 0 12308 8.80 D 141460 D Emp. Stock Option (Right to Buy) 3.78 2017-03-16 4 M 0 23955 0 D 2012-07-01 2021-07-01 Common Stock 23955 59055 D Emp. Stock Option (Right to Buy) 1.42 2017-03-16 4 M 0 12500 0 D 2014-01-01 2023-01-01 Common Stock 12500 75000 D Shares of Common Stock delivered to the Company to satisfy payment of exercise price in connection with stock option exercise. /s/ Alane P. Barnes, by power of attorney 2017-03-20